Safety and efficacy of neoadjuvant treatment with immune checkpoint inhibitors in esophageal cancer: real-world multicenter retrospective study in China

Immune checkpoint inhibitors (ICIs) have shown a powerful benefit in the neoadjuvant therapy for esophageal cancer, but evidence for its safety and efficacy is limited and may not reflect real-world practice. We retrospectively reviewed the database of treatment-naive patients from 15 esophageal can...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diseases of the esophagus 2022-11, Vol.35 (11)
Hauptverfasser:	Yang, Yang, Tan, Lijie, Hu, Jian, Li, Yin, Mao, Yousheng, Tian, Ziqiang, Zhang, Baihua, Ma, Jianqun, Li, Hecheng, Chen, Chun, Chen, Keneng, Han, Yongtao, Chen, Longqi, Liu, Junfeng, Yu, Bentong, Yu, Zhentao, Li, Zhigang
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!